MedTrace Logo

Impact of Patient Blood Management (PBM) at the Schulthess Clinic

NCT06363214 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 16000

Last updated 2024-04-16

No results posted yet for this study

Summary

Aim of this study is to analyze the transfusion requirements of allogenic blood products at the Schulthess Clinic for patients that had major orthopedic or major spine surgery between 2019 and 2024 order to identify patients at risk for transfusion. Moreover, impact of transfusion requirements and other measures of PBM on patient outcomes will be assessed. These data are required to further improve PBM at the Schulthess Clinic.

Conditions

  • Patient Blood Management

Interventions

PROCEDURE

Patient blood management

Perioperative optimization of hemoglobin level, perioperative minimization of blood loss, increase of anemia tolerance

Sponsors & Collaborators

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Christoph K Hofer, MD · Schulthess Klinik

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-02-28
Completion
2025-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06363214 on ClinicalTrials.gov